First in Human: who and what makes a cancer phase 1 trial and why are they so important?

Welisch, G. et al. (2021) First in Human: who and what makes a cancer phase 1 trial and why are they so important? Project Report. OSF. (doi: 10.17605/OSF.IO/KWHQF).

Abstract

Bringing new cancer therapies into routine cancer care is a long and complex process. Phase 1 clinical trials assess new cancer treatments in people for the first time. It is a critical step in the pathway. The aim of this project is to make the world of a cancer Phase 1 trialist and the value they bring, understandable to others. From those interested in careers in cancer clinical trials to stakeholders and partners seeking to innovate across the cancer control continuum, through a deeper understanding and insight of those involved.

• Item Type: Research Reports or Papers (Project Report)
• Additional Information: Full Project resources are available from https://doi.org/10.17605/OSF.IO/KWHQF.
• Status: Published
• Glasgow Author(s) Enlighten ID: Evans, Professor Jeff and Halsey, Professor Chris and Jones, Professor Robert and Keith, Professor Nicol and Hanna, Catherine and White, Dr Mark and Welisch, Mr Gaston
• Authors: Welisch, G., Twelves, C., Plummer, R., Evans, J., Danson, S., Symeonides, S., Halsey, C., Jones, R., Hanna, C., Gallagher, P., Walls, G., Taylor, K., Barnett, S., Forde, C., White, M., Williams, C., El Badri, S., Chipole, B.'e. D., and Keith, N.
• College/School: College of Medical Veterinary and Life Sciences > School of Cancer Sciences
• Publisher: OSF
• Published Online: 09 June 2021
• Copyright Holders: Copyright © 2021 The Authors
• Publisher Policy: Reproduced under a Creative Commons License